Anti-tumor and immunomodulatory activity of intraperitoneal IFN-gamma in ovarian carcinoma patients with minimal residual tumor after chemotherapy.
about
The interaction of anticancer therapies with tumor-associated macrophagesMetabolic reprograming in macrophage polarization.The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.Monocyte and interferon based therapy for the treatment of ovarian cancer.Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial.Metabolic Factors that Contribute to Lupus PathogenesisTumor immune surveillance and ovarian cancer: lessons on immune mediated tumor rejection or tolerance.Nanomedicine and cancer immunotherapy - targeting immunosuppressive cells.Tumour-associated macrophages as treatment targets in oncology.Perspectives in the field of drug metabolism.Interleukin (IL)-18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor.A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron (Peginterferon alfa-2b) and Actimmune (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer
P2860
Q27016634-643839DB-9F24-4B91-AA2C-8FBA0CAA5502Q34117016-95D3D956-BB47-4F73-A130-4B34ED12E84FQ35058213-959FCDD5-E681-40DF-A1F7-E12767335671Q35973378-FB3DCB6B-74AE-4B42-9AF8-9C178E3F53BAQ36621312-238EFB2F-7F60-4EB5-9936-82A73E791CC4Q37612885-8A70AF22-7C28-41E9-88CD-4155692840EBQ37836612-77689A2A-A7C1-40DD-BF09-56BF14014EF6Q38603362-BEB53680-5673-4F60-ADBA-86F548DCE0C1Q39100693-1A654933-D44D-4CDF-B228-73A7BD9248C6Q40632141-07B68182-2F1D-41B9-AD33-5E0DC47DF1D9Q45807012-028C1C3B-E5C5-418C-B97E-F7553F016184Q56517336-9C551B3D-450E-416E-A94C-F78AAB93BB70
P2860
Anti-tumor and immunomodulatory activity of intraperitoneal IFN-gamma in ovarian carcinoma patients with minimal residual tumor after chemotherapy.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Anti-tumor and immunomodulator ...... dual tumor after chemotherapy.
@en
type
label
Anti-tumor and immunomodulator ...... dual tumor after chemotherapy.
@en
prefLabel
Anti-tumor and immunomodulator ...... dual tumor after chemotherapy.
@en
P2093
P356
P1476
Anti-tumor and immunomodulator ...... dual tumor after chemotherapy.
@en
P2093
C Mangioni
F Peccatori
M Brandely
P Allavena
P2860
P356
10.1002/IJC.2910510109
P577
1992-04-01T00:00:00Z